Get started
Sensei Biotherapeutics, Inc.Sensei Biotherapeutics, Inc.Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SNSE chart


Full chart

SNSE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.32 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.1882 USD
Net income (FY)
‪−34.10 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪16.54 M‬
Beta (1Y)
0.77

Employees


Employees (FY)
27
Change (1Y)
−1 −3.57%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.26 M‬ USD

About Sensei Biotherapeutics, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
John K. Celebi
Website
senseibio.com
Headquarters
Rockville
Founded
1999
FIGI
BBG00V3M3TP5
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SNSE news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where SNSE is featured.

See all sparks 

Frequently Asked Questions


The current price of SNSE is 0.4499 USD — it has increased by 4.63% in the past 24 hours. Watch Sensei Biotherapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sensei Biotherapeutics, Inc. stocks are traded under the ticker SNSE.
SNSE stock has risen by 4.14% compared to the previous week, the month change is a −6.27% fall, over the last year Sensei Biotherapeutics, Inc. has showed a −27.88% decrease.
We've gathered analysts' opinions on Sensei Biotherapeutics, Inc. future price: according to them, SNSE price has a max estimate of 5.00 USD and a min estimate of 3.50 USD. Watch SNSE chart and read a more detailed Sensei Biotherapeutics, Inc. stock forecast: see what analysts think of Sensei Biotherapeutics, Inc. and suggest that you do with its stocks.
SNSE reached its all-time high on Feb 4, 2021 with the price of 26.5000 USD, and its all-time low was 0.3840 USD and was reached on Sep 16, 2024. View more price dynamics on SNSE chart.
See other stocks reaching their highest and lowest prices.
SNSE stock is 11.90% volatile and has beta coefficient of 0.77. Track Sensei Biotherapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Sensei Biotherapeutics, Inc. there?
Today Sensei Biotherapeutics, Inc. has the market capitalization of ‪11.32 M‬, it has increased by 11.20% over the last week.
Yes, you can track Sensei Biotherapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Sensei Biotherapeutics, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SNSE earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.31 USD resulting in a 7.00% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about Sensei Biotherapeutics, Inc. earnings.
Sensei Biotherapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SNSE net income for the last quarter is ‪−7.25 M‬ USD, while the quarter before that showed ‪−7.14 M‬ USD of net income which accounts for −1.55% change. Track more Sensei Biotherapeutics, Inc. financial stats to get the full picture.
No, SNSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 27.00 employees. See our rating of the largest employees — is Sensei Biotherapeutics, Inc. on this list?
Like other stocks, SNSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sensei Biotherapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sensei Biotherapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sensei Biotherapeutics, Inc. stock shows the sell signal. See more of Sensei Biotherapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.